Arcellx and Kite Pharma are planning to launch a Phase 3 clinical trial, dubbed iMMagine-3, to…
Articles by Marisa Wexler, MS
At its 15th annual gala, held in New York City this April, the International Myeloma Foundation (IMF) raised more…
A dysregulated immune response against viruses that cause hepatitis may lead to some cases of multiple myeloma (MM) —…
Adding Darzalex Faspro (daratumumab and hyaluronidase) — a subcutaneous or under-the-skin formulation of Darzalex (daratumumab) — to a standard…
The U.S. Food and Drug Administration (FDA) is delaying its review of an application that seeks to allow the cell…
A committee of the European Medicines Agency (EMA) has recommended that Elrexfio (elranatamab) — a therapy already in use…
While diabetes is more frequent among Black people than white people, it’s associated with poorer survival outcomes in white people…
People with hard-to-treat multiple myeloma given a regimen of Venclexta (venetoclax) plus dexamethasone lived longer than those treated with…
Nanjing Leads Biolabs is planning to launch a first-in-human clinical trial to test LBL-034, an antibody-based therapy designed to…
Researchers at Tel Aviv University in Israel have developed a new nanoparticle system that can deliver RNA-based therapies designed to…